AngioDynamics
ANGO
147 hedge funds and large institutions have $549M invested in AngioDynamics in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 59 reducing their positions, and 13 closing their positions.
265% more call options, than puts
Call options by funds: $581K | Put options by funds: $159K
69% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 13
28% more capital invested
Capital invested by funds: $428M → $549M (+$121M)
7% more funds holding
Funds holding: 138 → 147 (+9)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.07% less ownership
Funds ownership: 95.29% → 94.21% (-1.1%)
32% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 59
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$6.59M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.64M |
| 3 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$4.57M |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$2.69M |
| 5 |
Morgan Stanley
New York
|
+$2.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$7.04M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$6.2M |
| 3 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$4.18M |
| 4 |
Renaissance Technologies
New York
|
-$2.86M |
| 5 |
RA
Royce & Associates
New York
|
-$2.16M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SSA
151
Schonfeld Strategic Advisors
New York
| – | -$248K | -20,555 | Closed |
|
152
Axa
Paris,
France
| – | -$163K | -13,500 | Closed |
|
|
PI
153
PEAK6 Investments
Chicago,
Illinois
| – | -$22.2K | -1,753 | Closed |
|
|
GT
154
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$15K | -1,256 | Closed |
|
|
QT
155
Quantbot Technologies
New York
| – | -$14K | -1,185 | Closed |
|
|
VWM
156
Venturi Wealth Management
Austin,
Texas
| – | -$11K | -914 | Closed |
|
|
EI
157
Ellevest Inc
New York
| – | +$317 | +25 | New |
|
|
TF
158
Tompkins Financial
Ithaca,
New York
| – | +$381 | +30 | New |
|
ANGO Hedge Fund Activity: Q4 2020 in Review
147 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2020, worth a combined $549M — up 28% from $428M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ANGO positions and 13 closed out — a net gain of 9 holders — while 40 added to existing stakes and 59 trimmed.
The largest buyer was Camber Capital Management, adding an estimated $6.59M. The largest seller was Assenagon Asset Management, cutting an estimated $7.04M.
- 147 institutional investors held AngioDynamics (ANGO) as of Q4 2020, up from 138 in Q3 2020.
- Funds reported $549M of AngioDynamics stock for Q4 2020, up 28% quarter-over-quarter.
- 22 funds opened new AngioDynamics positions in Q4 2020 and 13 closed out, a net change of +9 holders.
- The largest AngioDynamics buyer in Q4 2020 was Camber Capital Management, an estimated $6.59M added.
- The largest AngioDynamics seller in Q4 2020 was Assenagon Asset Management, an estimated $7.04M sold.
Based on aggregated 13F filings for Q4 2020.